Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119110313 | 11911031 | 3 | F | 20150330 | 20160616 | 20160112 | 20160701 | EXP | JP-INCYTE CORPORATION-2015IN006989 | INCYTE | 50.08 | YR | F | Y | 0.00000 | 20160701 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119110313 | 11911031 | 1 | PS | JAKAFI | RUXOLITINIB | 1 | Oral | 5 MG, QD | 70 | MG | N | 202192 | 5 | MG | TABLET | ||||
| 119110313 | 11911031 | 2 | SS | PREDONINE | PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE | 1 | Oral | 10 MG, QD | 0 | 10 | MG | ||||||||
| 119110313 | 11911031 | 3 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | Oral | 200 MG, UNK | 0 | ||||||||||
| 119110313 | 11911031 | 4 | C | BAKTAR | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 1 G, UNK | 0 | ||||||||||
| 119110313 | 11911031 | 5 | C | HYDREA | HYDROXYUREA | 1 | Oral | 500 MG, UNK | 0 | ||||||||||
| 119110313 | 11911031 | 6 | C | DANAZOL. | DANAZOL | 1 | Oral | 200 MG, UNK | 0 | ||||||||||
| 119110313 | 11911031 | 7 | C | RED CELLS CONCENTRATES-LEUKOCYTES REDUCED | 2 | Unknown | 4 IU, UNK | 0 | INJECTION | ||||||||||
| 119110313 | 11911031 | 8 | C | RED CELLS CONCENTRATES-LEUKOCYTES REDUCED | 2 | 4 IU, UNK | 0 | INJECTION | |||||||||||
| 119110313 | 11911031 | 9 | C | RED CELLS CONCENTRATES-LEUKOCYTES REDUCED | 2 | Unknown | 4 IU, UNK | 0 | INJECTION | ||||||||||
| 119110313 | 11911031 | 10 | C | RED CELLS CONCENTRATES-LEUKOCYTES REDUCED | 2 | Unknown | 4 IU, UNK | 0 | INJECTION | ||||||||||
| 119110313 | 11911031 | 11 | C | RED CELLS CONCENTRATES-LEUKOCYTES REDUCED | 2 | Unknown | 4 IU, UNK | 0 | INJECTION | ||||||||||
| 119110313 | 11911031 | 12 | C | RED CELLS CONCENTRATES-LEUKOCYTES REDUCED | 2 | Unknown | 4 IU, UNK | 0 | INJECTION | ||||||||||
| 119110313 | 11911031 | 13 | C | RED CELLS CONCENTRATES-LEUKOCYTES REDUCED | 2 | Unknown | 4 IU, UNK | 0 | INJECTION | ||||||||||
| 119110313 | 11911031 | 14 | C | RED CELLS CONCENTRATES-LEUKOCYTES REDUCED | 2 | Unknown | 4 IU, UNK | 0 | INJECTION | ||||||||||
| 119110313 | 11911031 | 15 | C | RED CELLS CONCENTRATES-LEUKOCYTES REDUCED | 2 | Unknown | 4 IU, UNK | 0 | INJECTION | ||||||||||
| 119110313 | 11911031 | 16 | C | RED CELLS CONCENTRATES-LEUKOCYTES REDUCED | 2 | Unknown | 4 IU, UNK | 0 | INJECTION | ||||||||||
| 119110313 | 11911031 | 17 | C | RED CELLS CONCENTRATES-LEUKOCYTES REDUCED | 2 | Unknown | 4 IU, UNK | 0 | INJECTION | ||||||||||
| 119110313 | 11911031 | 18 | C | RED CELLS CONCENTRATES-LEUKOCYTES REDUCED | 2 | Unknown | 4 IU, UNK | 0 | INJECTION | ||||||||||
| 119110313 | 11911031 | 19 | C | RED CELLS CONCENTRATES-LEUKOCYTES REDUCED | 2 | Unknown | 4 IU, UNK | 0 | INJECTION | ||||||||||
| 119110313 | 11911031 | 20 | C | RED CELLS CONCENTRATES-LEUKOCYTES REDUCED | 2 | Unknown | 4 IU, UNK | 0 | INJECTION | ||||||||||
| 119110313 | 11911031 | 21 | C | RED CELLS CONCENTRATES-LEUKOCYTES REDUCED | 2 | Unknown | 4 IU, UNK | 0 | INJECTION | ||||||||||
| 119110313 | 11911031 | 22 | C | RED CELLS CONCENTRATES-LEUKOCYTES REDUCED | 2 | Unknown | 4 IU, UNK | 0 | INJECTION | ||||||||||
| 119110313 | 11911031 | 23 | C | RED CELLS CONCENTRATES-LEUKOCYTES REDUCED | 2 | 4 IU, UNK | 0 | INJECTION | |||||||||||
| 119110313 | 11911031 | 24 | C | RED CELLS CONCENTRATES-LEUKOCYTES REDUCED | 2 | 4 DF, UNK | 0 | INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119110313 | 11911031 | 1 | Myelofibrosis |
| 119110313 | 11911031 | 2 | Myelofibrosis |
| 119110313 | 11911031 | 3 | Infection prophylaxis |
| 119110313 | 11911031 | 4 | Infection prophylaxis |
| 119110313 | 11911031 | 5 | Myelofibrosis |
| 119110313 | 11911031 | 6 | Myelofibrosis |
| 119110313 | 11911031 | 7 | Myelofibrosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119110313 | 11911031 | OT |
| 119110313 | 11911031 | DE |
| 119110313 | 11911031 | HO |
| 119110313 | 11911031 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119110313 | 11911031 | Back pain | |
| 119110313 | 11911031 | Cellulitis | |
| 119110313 | 11911031 | Diarrhoea | |
| 119110313 | 11911031 | Hypotension | |
| 119110313 | 11911031 | Myelofibrosis | |
| 119110313 | 11911031 | Oedema | |
| 119110313 | 11911031 | Shock | |
| 119110313 | 11911031 | Skin erosion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119110313 | 11911031 | 1 | 20150326 | 20150408 | 0 | |
| 119110313 | 11911031 | 6 | 20150128 | 0 | ||
| 119110313 | 11911031 | 7 | 20150423 | 0 | ||
| 119110313 | 11911031 | 8 | 20141120 | 0 | ||
| 119110313 | 11911031 | 9 | 20141127 | 0 | ||
| 119110313 | 11911031 | 10 | 20141211 | 0 | ||
| 119110313 | 11911031 | 11 | 20141225 | 0 | ||
| 119110313 | 11911031 | 12 | 20150108 | 0 | ||
| 119110313 | 11911031 | 13 | 20150115 | 0 | ||
| 119110313 | 11911031 | 14 | 20150129 | 0 | ||
| 119110313 | 11911031 | 15 | 20150205 | 0 | ||
| 119110313 | 11911031 | 16 | 20150217 | 0 | ||
| 119110313 | 11911031 | 17 | 20150226 | 0 | ||
| 119110313 | 11911031 | 18 | 20150305 | 0 | ||
| 119110313 | 11911031 | 19 | 20150312 | 0 | ||
| 119110313 | 11911031 | 20 | 20150326 | 0 | ||
| 119110313 | 11911031 | 21 | 20150402 | 0 | ||
| 119110313 | 11911031 | 22 | 20150409 | 0 | ||
| 119110313 | 11911031 | 23 | 20160416 | 0 | ||
| 119110313 | 11911031 | 24 | 20160423 | 0 |